Pliant Therapeutics Cash Flow Statement (2019-2026) | PLRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-22.83M	-27.05M	-24.53M	-28.10M	-29.55M	-30.61M	-35.06M	-37.55M	-41.19M	-41.49M	-41.11M	-46.95M	-55.85M	-57.76M	-49.73M	-56.17M	-43.30M	-26.30M	-21.75M	-20.04M
Depreciation and Depletion (Quarter)	0.40M	0.40M	0.40M	0.50M	0.40M	0.50M	0.43M	0.50M	0.40M	0.50M	0.42M	0.50M	0.60M	0.50M	0.43M	0.40M	0.40M	0.40M	0.37M	0.26M
Share-based Compensation (Quarter)	2.28M	2.81M	2.77M	3.53M	3.40M	4.81M	10.86M	11.92M	13.05M	10.36M	9.15M	9.67M	10.64M	8.90M	8.42M	8.91M	6.38M	6.42M	4.53M	4.25M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)			-0.07M	-0.21M	0.21M	0.95M	-1.15M					23.70M	6.10M		-29.74M	-0.01M	0.01M			-0.32M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-19.40M	-22.51M	-19.86M	-20.50M	-24.40M	-18.50M	-31.24M	-30.28M	-24.76M	-36.22M	-25.10M	-30.27M	-45.30M	-32.27M	-47.66M	-48.86M	-40.60M	-21.08M	-17.79M	-19.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.09M	0.42M	0.81M	0.24M	-0.69M	0.71M	1.59M	2.58M	3.93M	3.70M	-7.83M	0.68M	1.15M	0.81M	0.81M	0.81M	0.81M	0.82M	0.83M	0.83M
Depreciation & Amortization (CF) (Quarter)	0.40M	0.40M	0.40M	0.50M	0.40M	0.50M	0.43M	0.50M	0.40M	0.50M	0.42M	0.50M	0.60M	0.50M	0.43M	0.40M	0.40M	0.40M	0.37M	0.26M
Change in Working Capital
Change in Receivables (Quarter)	-0.34M	-0.22M	0.39M	-0.75M	3.74M	-3.51M	0.50M	1.31M	-1.72M	-1.58M
Change in Account Payables (Quarter)	0.08M	-0.34M	0.49M	1.77M	-1.57M	0.05M	-1.60M	-0.14M	0.88M	1.06M	1.17M	2.26M	-3.63M	3.73M	-0.93M	-0.34M	-4.24M	-0.90M	-0.00M	-0.12M
Change in Accured Expenses (Quarter)	0.76M	2.05M	1.98M	-0.36M	5.77M	2.91M	-0.41M	-0.54M	5.62M	-3.00M	0.70M	-0.91M	5.68M	5.17M	-6.13M	-4.81M	-3.81M	-2.03M	-1.51M	-6.47M
Change in Taxes (Quarter)
Investing Activities
Capital Expenditures (Quarter)	-0.16M	1.28M	-1.30M	0.64M	-0.64M	1.59M	-1.59M	0.16M	0.60M	0.09M	0.06M	1.49M	-1.27M	3.42M	0.21M	0.26M	-0.15M	0.26M	-0.26M
Sales of Property, Plant and Equipment (Quarter)																			-0.00M	0.10M
Change in Acquisitions & Divestments (Quarter)	78.25M	75.72M	64.30M	41.40M	45.57M	33.80M	56.50M	102.58M	112.10M	152.82M	89.48M	113.41M	60.48M	108.89M	72.70M	83.53M	87.21M	80.33M	86.85M	60.70M
Cash from Investing Activities (Quarter)	3.58M	32.10M	25.78M	1.53M	6.50M	-178.25M	20.02M	-174.21M	-22.98M	38.25M	31.92M	59.55M	10.70M	30.96M	39.13M	69.11M	35.49M	27.92M	1.77M	-4.10M
Financing Activities
Other financing activities (Quarter)
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)							-0.15M					19.91M			0.00M
Change in Capital Stock
Shares Issued (Quarter)	0.37M	0.70M	-2.44M			216.20M		270.25M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	0.19M	0.45M	0.52M	-0.15M	10.43M	216.30M	0.28M	273.33M	0.16M	0.70M	0.22M	21.79M	0.68M	0.54M	0.10M	0.50M		0.07M	-32.27M	0.07M
Change in Cash (Quarter)	-15.63M	10.04M	6.43M	-19.12M	-7.47M	19.55M	-10.93M	68.84M	-47.58M	2.73M	7.04M	51.06M	-33.91M	-0.77M	-8.43M	20.75M	-5.12M	6.91M	-48.29M	-23.25M
Free Cash Flow (Quarter)	-19.24M	-23.79M	-18.56M	-21.14M	-23.75M	-20.09M	-29.64M	-30.44M	-25.36M	-36.32M	-25.16M	-31.76M	-44.02M	-35.69M	-47.87M	-49.13M	-40.45M	-21.34M	-17.53M	-19.23M
Net Cash Flow (Quarter)	-15.63M	10.04M	6.43M	-19.12M	-7.47M	19.55M	-10.93M	68.84M	-47.58M	2.73M	7.04M	51.06M	-33.91M	-0.77M	-8.43M	20.75M	-5.12M	6.91M	-48.29M	-23.25M

Research Tools

Pliant Therapeutics Cash Flow Statement (2019-2026) | PLRX

Create an account

Sign In

Reset Password